Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
The highly-anticipated fifth edition is here! Get the must-have resource for achieving compliance with medical device regulations.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 15 August 2013 | By Louise Zornoza,
In a recent interview with the press, China Food and Drug Administration (CFDA) Commissioner Zhang Yong noted that the country has entered a development phase for regulated industry that is marked by a high incidence of safety risks.
He attributes this current phase to the country's rapid economic development, which has also led to the rapid growth of local regulated industry. Based on international experience as a reference point, China's regulated industry is still burdened by imperfect self-regulation and the need for better recognition of the importance of product safety and quality.
In his opinion, there is a close relationship between product safety and quality and a country's social and economic development, and the public is now demanding that from industry.
SFDA Statement on Interview
Read all Breaking News from RegLink